Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

The restaurant group announced Tuesday that Jose Alberto Dueñas is stepping down. Chief financial officer Paul Carbone, a ...

The issue, which has a price band set between ₹275-290 per share for its initial offering, is set to open for public ...

Indobell Insulation’s IPO, worth ₹10.14 crore, was fully subscribed on its first day. The offering is priced at ₹46 per share ...

Medical technology firm Brainlab AG has asked for bank proposals for its potential initial public offering in Frankfurt, ...

Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...

Nice One Beauty Digital Marketing Co. surged in its debut after a $320 million initial public offering in Riyadh, the latest ...

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

Smithfield Foods on Monday made public its paperwork for its New York initial public offering as the maker of Farmland bacon ...

The Quadrant Future Tek IPO was subscribed 48.99 times as of 5:00 PM IST on the second day of its offering, according to data ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.